Accepted for Publication: October 2, 2020.
Published Online: December 14, 2020. doi:10.1001/jamainternmed.2020.7090
Corresponding Author: Rebecca Erwin Wells, MD, MPH, Comprehensive Headache Program, Department of Neurology, Wake Forest Baptist Health, Medical Center Blvd, Janeway Tower, Winston-Salem, NC 27157 (rewells@wakehealth.edu).
Author Contributions: Dr Wells had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Wells, Zeidan, Penzien, Loder, Houle.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Wells, Zeidan, Pierce, Penzien, Loder, O’Connell, Houle.
Critical revision of the manuscript for important intellectual content: Wells, Zeidan, Estave, Penzien, Loder, O’Connell, Houle.
Statistical analysis: Wells, Zeidan, O’Connell, Houle.
Obtained funding: Wells, Zeidan.
Administrative, technical, or material support: Wells, Zeidan, Pierce, Penzien.
Supervision: Wells, Zeidan, Penzien, Loder, Houle.
Conflict of Interest Disclosures: Drs Wells and Zeidan reported grants from the National Institutes of Health during the conduct of the study. Dr Houle reported personal fees from GlaxoSmithKline, Eli Lilly, and StatReviewer outside the submitted work. No other disclosures were reported.
Funding/Support: This study was funded by an American Pain Society Grant from the Sharon S. Keller Chronic Pain Research Program, as well as the National Center for Complementary and Integrative Health K23AT008406, R21-AT010352, K99-R00 AT008238, and R01AT009693.
Role of the Funder/Sponsor: The American Pain Society and the National Center for Complementary and Integrative Health had no role in the collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Data Sharing Statement: See Supplement 3.
Additional Contributions: This study was an extraordinary team effort, and we appreciate all the support and help of all those involved. We appreciate all the participants in this study. We are thankful for all the health care professionals who referred patients into the study, including but not limited to Lauren Strauss, DO; Laura Granetzke, MSN; Vanessa Baute Penry, MD; Cormac O’Donovan, MD; Starla Wise, DO; Sandhya Kumar, MD; Nada El-Husseini, MD, MHS; Jane Boggs, MD; Jessica Tate, MD; Heidi Munger Clary, MD, MPH; and Clark W. Pinyan, MD, MPH. We are appreciative of our MBSR instructor, Ann McCarty, PA, and our headache education instructor, Megan Irby, PhD, who were compensated for their roles in this study. We are grateful for the support of the Wake Forest Baptist Department of Neurology, Allison Brashear, MD, Charles Tegeler, MD, Kevin Shuping, and the Comprehensive Headache Program. We are grateful for the help from the Maya Angelou Center for Health Equity for help in diverse recruitment and study participation. Special thanks to Claudia Nielson, Steve Thomas, and the Creative Communications Design Team and Sarah Diamont with Marketing at Wake Forest Baptist Health. We appreciate the support of Brian Moore and the Wake Forest Institutional Review Board and Data and Safety Monitoring Board. We appreciate the support from the Wake Forest Clinical Translational Science Institute (CTSI), the Clinical Research Unit staff and support, and the Research Coordinator Pool, funded by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR001420, who helped support the significant research coordinator support from Emily Ansusinha, Elizabeth Crenshaw, Carolyn Hedrick, Sandra Norona, Nancy Lawlor, and Brittany Briceno. We are so thankful for the additional research coordination support from Imani Randolph, MA, Jason Collier, Grace Posey, MS, and Georgeta Lester, who were compensated for their efforts. This study would not have been completed without the tremendous support of a multitude of volunteer students, including Nicole Rojas, Hudaisa Fatima, Obiageli Nwamu, MA, Vinish Kumar, Rosalia Arnolda, Paige Brabant, Danika Berman, Nicholas Contillo, Flora Chang, Geena George, Easton Howard, Caitlyn Margol, Mariam Shakir, Reid Anderson, Camden Nelson, Carson DeLong, Summerlyn Beeghly, and Anissa Berger. Several of the students received American Academy of Neurology Neuroscience is Rewarding Internship scholarship awards for their work on this project, including Nicholas Contillo, Flora Chang, Caitlyn Margo, Easton Howard, Geena George, Reid Anderson, Mariam Shakir, Anissa Berger, and Summerlyn Beeghly.
1.GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet. 2018;392(10159):1789-1858. doi:
10.1016/S0140-6736(18)32279-7PubMedGoogle ScholarCrossref 2.Archibald
N , Lipscomb
J , McCrory
DC . Resource Utilization and Costs of Care for Treatment of Chronic Headache. In: AHRQ Technical Reviews and Summaries. US Agency for Health Care Policy and Research; 1999.
3.Lipton
RB , Hutchinson
S , Ailani
J ,
et al. Discontinuation of acute prescription medication for migraine: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Headache. 2019;59(10):1762-1772.
PubMedGoogle ScholarCrossref 4.Loder
E , Weizenbaum
E , Frishberg
B , Silberstein
S ; American Headache Society Choosing Wisely Task Force. Choosing wisely in headache medicine: the American Headache Society’s list of five things physicians and patients should question.
Headache. 2013;53(10):1651-1659. doi:
10.1111/head.12233PubMedGoogle ScholarCrossref 8.Rosenzweig
S , Greeson
JM , Reibel
DK , Green
JS , Jasser
SA , Beasley
D . Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice.
J Psychosom Res. 2010;68(1):29-36. doi:
10.1016/j.jpsychores.2009.03.010PubMedGoogle ScholarCrossref 9.Cherkin
DC , Sherman
KJ , Balderson
BH ,
et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial.
JAMA. 2016;315(12):1240-1249. doi:
10.1001/jama.2016.2323PubMedGoogle ScholarCrossref 12.Hoge
EA , Bui
E , Marques
L ,
et al. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity.
J Clin Psychiatry. 2013;74(8):786-792. doi:
10.4088/JCP.12m08083PubMedGoogle ScholarCrossref 17.Seng
EK , Buse
DC , Klepper
JE ,
et al. Psychological factors associated with chronic migraine and severe migraine-related disability: an observational study in a tertiary headache center.
Headache. 2017;57(4):593-604. doi:
10.1111/head.13021PubMedGoogle ScholarCrossref 18.Buse
DC , Reed
ML , Fanning
KM ,
et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
J Headache Pain. 2020;21(1):23. doi:
10.1186/s10194-020-1084-yPubMedGoogle ScholarCrossref 20.Zhang
Y , Dennis
JA , Leach
MJ ,
et al. Complementary and alternative medicine use among US adults with headache or migraine: results from the 2012 National Health Interview Survey.
Headache. 2017;57(8):1228-1242. doi:
10.1111/head.13148PubMedGoogle ScholarCrossref 23.Day
MA , Thorn
BE , Ward
LC ,
et al. Mindfulness-based cognitive therapy for the treatment of headache pain: a pilot study.
Clin J Pain. 2014;30(2):152-161.
PubMedGoogle ScholarCrossref 26.Smitherman
TA , Penzien
DB , Rains
JC , Nicholson
RA , Houle
TT . Headache: Advances in Psychotherapy-Evidence-Based Practice. Boston, MA: Hogrefe Publishing; 2015.
27.Serrano
D , Lipton
RB , Scher
AI ,
et al. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.
J Headache Pain. 2017;18(1):101. doi:
10.1186/s10194-017-0787-1PubMedGoogle ScholarCrossref 29.Tfelt-Hansen
P , Pascual
J , Ramadan
N ,
et al; International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators.
Cephalalgia. 2012;32(1):6-38.
PubMedGoogle ScholarCrossref 30.Penzien
DB , Andrasik
F , Freidenberg
BM ,
et al; American Headache Society Behavioral Clinical Trials Workgroup. Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup.
Headache. 2005;45(suppl 2):S110-S132.
PubMedGoogle ScholarCrossref 31.Santorelli
S , Meleo-Meyer
F , Koerbel
L , Kabat-Zinn
J. Mindfulness-Based Stress Reduction (MBSR) Authorized Curriculum Guide. Worcester, MA: University of Massachusetts Medical School Center for Mindfulness in Medicine, Health Care, and Society;2017.
32.Bellg
AJ , Borrelli
B , Resnick
B ,
et al; Treatment Fidelity Workgroup of the NIH Behavior Change Consortium. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium.
Health Psychol. 2004;23(5):443-451.
PubMedGoogle ScholarCrossref 34.Hoffmann
TC , Glasziou
PP , Boutron
I ,
et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
BMJ. 2014;348:g1687. doi:
10.1136/bmj.g1687PubMedGoogle ScholarCrossref 37.Pbert
L , Adams
A , Quirk
M , Hebert
JR , Ockene
JK , Luippold
RS . The patient exit interview as an assessment of physician-delivered smoking intervention: a validation study.
Health Psychol. 1999;18(2):183-188.
PubMedGoogle ScholarCrossref 38.Harris
PA , Taylor
R , Thielke
R , Payne
J , Gonzalez
N , Conde
JG . Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.
J Biomed Inform. 2009;42(2):377-381. doi:
10.1016/j.jbi.2008.08.010PubMedGoogle ScholarCrossref 58.R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2018.
59.van Buuren
S , Groothuis-Oudshoorn
K. mice: Multivariate Imputation by Chained Equations in R.
Journal of Statistical Software. 2011;45(3):1-67. doi:
10.18637/jss.v045.i03Google Scholar 61.Buse
DC , Lipton
RB , Hallström
Y ,
et al. Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
Cephalalgia. 2018;38(10):1622-1631.
PubMedGoogle ScholarCrossref 62.Cohen
J. Statistical Power Analysis for the Behavioral Sciences. United States of America: Lawrence Erlbaum Associates; 1988.
66.Kindelan-Calvo
P , Gil-Martínez
A , Paris-Alemany
A ,
et al. Effectiveness of therapeutic patient education for adults with migraine. A systematic review and meta-analysis of randomized controlled trials.
Pain Med. 2014;15(9):1619-1636. doi:
10.1111/pme.12505PubMedGoogle ScholarCrossref 68.Kabat-Zinn
J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. New York: Random House; 1990.
69.Seng
EK , Singer
AB , Metts
C ,
et al. Does mindfulness-based cognitive therapy for migraine reduce migraine-related disability in people with episodic and chronic migraine? a phase 2b pilot randomized clinical trial.
Headache. 2019;59(9):1448-1467. doi:
10.1111/head.13657PubMedGoogle ScholarCrossref 70.Anheyer
D , Leach
MJ , Klose
P , Dobos
G , Cramer
H . Mindfulness-based stress reduction for treating chronic headache: a systematic review and meta-analysis.
Cephalalgia. 2019;39(4):544-555.
PubMedGoogle ScholarCrossref 71.Grazzi
L , Sansone
E , Raggi
A ,
et al. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with chronic migraine: an effectiveness trial with a one-year follow-up.
J Headache Pain. 2017;18(1):15. doi:
10.1186/s10194-017-0728-zPubMedGoogle ScholarCrossref 72.Seminowicz
DA , Burrowes
SAB , Kearson
A ,
et al Enhanced mindfulness-based stress reduction in episodic migraine: a randomized clinical trial with magnetic resonance imaging outcomes.
Pain. Published online March 13, 2020. doi:
10.1097/j.pain.0000000000001860Google Scholar 73.Silberstein
SD , Stauffer
VL , Day
KA , Lipsius
S , Wilson
MC . Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
J Headache Pain. 2019;20(1):75. doi:
10.1186/s10194-019-1024-xPubMedGoogle ScholarCrossref 75.Lipton
RB , Desai
P , Sapra
S , Buse
DC , Fanning
KM , Reed
ML . How much change in headache-related disability is clinically meaningful? estimating minimally important difference (MID) or change in MIDAS using data from the AMPP study.
Headache. 2017;57(53):165-166.
Google Scholar 76.Pressman
A , Law
H , Stahl
R ,
et al. Conducting a pilot randomized controlled trial of community-based mindfulness-based stress reduction versus usual care for moderate-to-severe migraine: protocol for the Mindfulness and Migraine Study (M&M).
Trials. 2019;20(1):257. doi:
10.1186/s13063-019-3355-yPubMedGoogle ScholarCrossref 77.Grazzi
L , Bernstein
C , Raggi
A ,
et al. ACT for migraine: effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: preliminary data of a phase-II, multicentric, randomized, open-label study.
Neurol Sci. 2019;40(suppl 1):191-192.
PubMedGoogle ScholarCrossref 80.Chowdhury
D , Datta
D . Managing migraine in the times of COVID-19 pandemic.
Ann Indian Acad Neurol. 2020;23(suppl 1):S33-S39.
PubMedGoogle Scholar